Additionally, STK38l is situated within a cryptic translocation site found in patients with Kallmann syndrome, and the ECM molecule ANOSMIN‐1, produced by the KAL1 gene, has been demonstrated to activate β1 integrins (Choy et al. 2014; Endo et al. 2018). The gene discussed is STK38L; the disease is Kallmann syndrome.